Philipp J Jost

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 25

Top Topics

Abdominal Aortic Aneurysm

Top Venues

British journal of cancer

Cell death & disease

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, Maria Eugenia Olmedo, Michael J Boyer, Kai He, Neeltje Steeghs, Hiroki Izumi, Melissa Lynne Johnson, Tatsuya Yoshida, Hasna Bouchaab, Hossein Borghaei, Enriqueta Felip Font, Philipp J Jost, Shirish M Gadgeel, Xi Chen, Youfei Yu, Pablo Martinez, Amanda Parkes, Luis G Paz-Ares
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer 131 (2) (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer 131 (2) (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer 131 (2) (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer 131 (2) (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer 131 (2) (2024)
Heikki Joensuu, Eva Wardelmann, Mikael Eriksson, Annette Reichardt, Kirsten Sundby Hall, Jochen Schütte, Silke Cameron, Peter Hohenberger, Harri Jaakko Sihto, Philipp J Jost, Lars Hartwin Lindner, Sebastian Bauer, Bengt Nilsson, Raija Kallio, Tommi Pesonen, Peter Reichardt
KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jakob M Riedl, Florian Moik, Tamara Esterl, Sarah M Kostmann, Armin Gerger, Philipp J Jost
Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view. Virchows Archiv : an international journal of pathology (2023)
Anna-Lena Meinhardt, Enkhtsetseg Munkhbaatar, Ulrike Höckendorf, Michelle Dietzen, Marta Dechant, Martina Anton, Anne Jacob, Katja Steiger, Wilko Weichert, Luka Brcic, Nicholas McGranahan, Caterina Branca, Thomas Kaufmann, Michael A Dengler, Philipp J Jost
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner. Oncogene 41 (9) (2022)
Xin Wang, Uris Ros, Deepti Agrawal, Eva C Keller, Julia Slotta-Huspenina, Veronika Dill, Bo Shen, Run Shi, Tobias Herold, Claus Belka, Ritu Mishra, Florian Bassermann, Ana J Garcia-Saez, Philipp J Jost
Correction: MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF. Cell death and differentiation (2021)
Matthias Huemer, Daniela Jahn-Kuch, Guenter Hofmann, Elisabeth Andritsch, Clemens Farkas, Walter Schaupp, Eva Katharina Masel, Philipp J Jost, Martin Pichler
Trends and Patterns in the Public Awareness of Palliative Care, Euthanasia, and End-of-Life Decisions in 3 Central European Countries Using Big Data Analysis From Google: Retrospective Analysis. Journal of medical Internet research 23 (9) (2021)
Peter Horak, Christoph Heining, Simon Kreutzfeldt, Barbara Hutter, Andreas Mock, Jennifer Hüllein, Martina Fröhlich, Sebastian Uhrig, Arne Jahn, Andreas Rump, Laura Gieldon, Lino Möhrmann, Dorothea Hanf, Veronica Teleanu, Christoph E Heilig, Daniel B Lipka, Michael Allgäuer, Leo Ruhnke, Andreas Laßmann, Volker Endris, Olaf Neumann, Roland Penzel, Katja Beck, Daniela Richter, Ulrike Winter, Stephan Wolf, Katrin Pfütze, Christina Geörg, Bettina Meißburger, Ivo Buchhalter, Marinela Augustin, Walter E Aulitzky, Peter Hohenberger, Matthias Kroiss, Peter Schirmacher, Richard F Schlenk, Ulrich Keilholz, Frederick Klauschen, Gunnar Folprecht, Sebastian Bauer, Jens Thomas Siveke, Christian H Brandts, Thomas Kindler, Melanie Börries, Anna L Illert, Nikolas von Bubnoff, Philipp J Jost, Karsten Spiekermann, Michael Bitzer, Klaus Schulze-Osthoff, Christof von Kalle, Barbara Klink, Benedikt Brors, Albrecht Stenzinger, Evelin Schröck, Daniel Hübschmann, Wilko Weichert, Hanno Glimm, Stefan Fröhling
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers. Cancer discovery 11 (11) (2021)
Xin Wang, Uris Ros, Deepti Agrawal, Eva C Keller, Julia Slotta-Huspenina, Veronika Dill, Bo Shen, Run Shi, Tobias Herold, Claus Belka, Ritu Mishra, Florian Bassermann, Ana J Garcia-Saez, Philipp J Jost
MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF. Cell death and differentiation 28 (12) (2021)
Anna-Lena Scherr, Andreas Mock, Georg Gdynia, Nathalie Schmitt, Christoph E Heilig, Felix Korell, Praveen Rhadakrishnan, Paula Hoffmeister, Klaus H Metzeler, Heike Bantel, Anna L Illert, Melanie Boerries, Jörg Trojan, Oliver Waidmann, Johanna Falkenhorst, Jens Siveke, Philipp J Jost, Michael Bitzer, Nisar P Malek, Loredana Vecchione, Ivan Jelas, Benedikt Brors, Hanno Glimm, Albrecht Stenzinger, Svetlana P Grekova, Tobias Gehrig, Henning Schulze-Bergkamen, Dirk Jäger, Peter Schirmacher, Mathias Heikenwalder, Benjamin Goeppert, Martin Schneider, Stefan Fröhling, Bruno C Köhler
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer. Cell death & disease 11 (10) (2020)
Ashok Kumar Jayavelu, Tina M Schnöder, Florian Perner, Carolin Herzog, Arno Meiler, Gurumoorthy Krishnamoorthy, Nicolas Huber, Juliane Mohr, Bärbel Edelmann-Stephan, Rebecca Austin, Sabine Brandt, Francesca Palandri, Nicolas Schröder, Berend Isermann, Frank Edlich, Amit U Sinha, Martin Ungelenk, Christian A Hübner, Robert Zeiser, Susann Rahmig, Claudia Waskow, Iain Coldham, Thomas Ernst, Andreas Hochhaus, Stefanie Jilg, Philipp J Jost, Ann Mullally, Lars Bullinger, Peter R Mertens, Steven W Lane, Matthias Mann, Florian H Heidel
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms. Nature 588 (7836) (2020)
Carl C Crodel, Kathleen Jentsch-Ullrich, Steffen Koschmieder, Dietrich Kämpfe, Martin Griesshammer, Konstanze Döhner, Philipp J Jost, Denise Wolleschak, Susanne Isfort, Frank Stegelmann, Stefanie Jilg, Verena Hofmann, Guiseppe Auteri, Tobias Rachow, Philipp Ernst, Annamaria Brioli, Marie von Lilienfeld-Toal, Andreas Hochhaus, Francesca Palandri, Florian H Heidel
Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study. Leukemia 34 (7) (2020)
Janin Knop, Lisanne M Spilgies, Stefanie Rufli, Ramona Reinhart, Lazaros Vasilikos, Monica Yabal, Erika Owsley, Philipp J Jost, Rebecca A Marsh, Harald Wajant, Mark D Robinson, Thomas Kaufmann, Wendy Wei-Lynn Wong
Correction: TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP. Cell death & disease 11 (1) (2020)
Enkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, Martina Anton, Moritz Jesinghaus, Melanie Boxberg, Nicole Pfarr, Pidassa Bidola, Sebastian Uhrig, Ulrike Höckendorf, Anna-Lena Meinhardt, Adam Wahida, Irina Heid, Rickmer F Braren, Ritu Mishra, Arne Warth, Thomas Muley, Patrina S P Poh, Xin Wang, Stefan Fröhling, Katja Steiger, Julia Slotta-Huspenina, Martijn van Griensven, Franz Pfeiffer, Sebastian Lange, Roland Rad, Magda Spella, Georgios T Stathopoulos, Juergen Ruland, Florian Bassermann, Wilko Weichert, Andreas Strasser, Caterina Branca, Mathias F Heikenwälder, Charles Swanton, Nicholas McGranahan, Philipp J Jost
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically. Nature communications 11 (1) (2020)
Janin Knop, Lisanne M Spilgies, Stefanie Rufli, Ramona Reinhart, Lazaros Vasilikos, Monica Yabal, Erika Owsley, Philipp J Jost, Rebecca A Marsh, Harald Wajant, Mark D Robinson, Thomas Kaufmann, Wendy Wei-Lynn Wong
TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP. Cell death & disease 10 (10) (2019)
Pidassa Bidola, Juliana Martins de Souza E Silva, Klaus Achterhold, Enkhtsetseg Munkhbaatar, Philipp J Jost, Anna-Lena Meinhardt, Kirsten Taphorn, Marie-Christine Zdora, Franz Pfeiffer, Julia Herzen
A step towards valid detection and quantification of lung cancer volume in experimental mice with contrast agent-based X-ray microtomography. Scientific reports 9 (1) (2019)
Nicole Müller, Julius C Fischer, Monica Yabal, Tobias Haas, Hendrik Poeck, Philipp J Jost
XIAP deficiency in hematopoietic recipient cells drives donor T-cell activation and GvHD in mice. European journal of immunology 49 (3) (2019)
Philipp J Jost, Ulrike Höckendorf
Necroinflammation emerges as a key regulator of hematopoiesis in health and disease. Cell death and differentiation 26 (1) (2018)
Simone Wicki, Ursina Gurzeler, W Wei-Lynn Wong, Philipp J Jost, Daniel Bachmann, Thomas Kaufmann
Loss of XIAP facilitates switch to TNFα-induced necroptosis in mouse neutrophils. Cell death & disease 7 (10) (2016)
Katharina Engel, Martina Rudelius, Jolanta Slawska, Laura Jacobs, Behnaz Ahangarian Abhari, Bettina Altmann, Julia Kurutz, Abirami Rathakrishnan, Vanesa Fernández-Sáiz, Andrä Brunner, Bianca-Sabrina Targosz, Felicia Loewecke, Christian Johannes Gloeckner, Marius Ueffing, Simone Fulda, Michael Pfreundschuh, Lorenz Trümper, Wolfram Klapper, Ulrich Keller, Philipp J Jost, Andreas Rosenwald, Christian Peschel, Florian Bassermann
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma. EMBO molecular medicine 8 (8) (2016)